Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Virpax Pharmaceuticals ( (VRPX) ) has issued an update.
Virpax Pharmaceuticals, Inc. has taken significant steps to enhance its governance and strategic initiatives. The company appointed Ms. Esha Randhawa as an independent director to meet Nasdaq’s compliance requirements following Dr. Eric Floyd’s resignation. Additionally, they signed an agreement with CEO Jatinder Dhaliwal through his firm to drive the company’s drug development efforts. Virpax also announced an extended collaboration with the NIH for NES100, an innovative pain management product, reflecting its commitment to non-addictive pain solutions.
Find detailed analytics on VRPX stock on TipRanks’ Stock Analysis page.
